Bio-Techne (TECH) EPS (Basic) (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.50% |
| Dec 31, 2025 | -4.00% |
| Sep 30, 2025 | 327.27% |
| Jun 30, 2025 | -178.57% |
| Mar 31, 2025 | -36.36% |
| Dec 31, 2024 | 4.76% |
| Sep 30, 2024 | -19.23% |
| Jun 30, 2024 | -16.13% |
| Mar 31, 2024 | 82.35% |
| Dec 31, 2023 | -46.88% |
| Sep 30, 2023 | -31.91% |
| Jun 30, 2023 | 4.44% |
| Mar 31, 2023 | 40.63% |
| Dec 31, 2022 | -43.86% |
| Sep 30, 2022 | 46.15% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -23.53% |
| Dec 31, 2021 | -71.35% |
| Sep 30, 2021 | 176.39% |
| Jun 30, 2021 | -297.46% |
| Mar 31, 2021 | -1.67% |
| Dec 31, 2020 | 37.93% |
| Sep 30, 2020 | -43.51% |
| Jun 30, 2020 | 62.11% |
| Mar 31, 2020 | -69.65% |
| Dec 31, 2019 | 723.68% |
| Sep 30, 2019 | -11.63% |
| Jun 30, 2019 | -63.56% |
| Mar 31, 2019 | 156.52% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | -57.80% |
| Jun 30, 2018 | 105.66% |
| Mar 31, 2018 | -59.23% |
| Dec 31, 2017 | 209.52% |
| Sep 30, 2017 | -43.24% |
| Jun 30, 2017 | 25.42% |
| Mar 31, 2017 | 195.00% |
| Dec 31, 2016 | -60.78% |
| Sep 30, 2016 | -26.09% |
| Jun 30, 2016 | -14.81% |
| Mar 31, 2016 | 15.71% |
| Dec 31, 2015 | 14.75% |
| Sep 30, 2015 | -12.86% |
| Jun 30, 2015 | 7.69% |
| Mar 31, 2015 | -27.78% |
| Dec 31, 2014 | 38.46% |
| Sep 30, 2014 | -10.96% |
| Jun 30, 2014 | -15.12% |
| Mar 31, 2014 | 26.47% |
| Dec 31, 2013 | -8.11% |
| Sep 30, 2013 | -5.13% |
| Jun 30, 2013 | -13.33% |
| Mar 31, 2013 | 30.43% |
| Dec 31, 2012 | -1.43% |
| Sep 30, 2012 | -5.41% |
| Jun 30, 2012 | -13.95% |
| Mar 31, 2012 | 22.86% |
| Dec 31, 2011 | -5.41% |
| Sep 30, 2011 | -3.90% |
| Jun 30, 2011 | -8.33% |
| Mar 31, 2011 | 16.67% |
| Dec 31, 2010 | 1.41% |
| Sep 30, 2010 | 1.43% |
| Jun 30, 2010 | -19.54% |
| Mar 31, 2010 | 31.82% |
| Dec 31, 2009 | -8.33% |